The cell based assays market is undergoing significant expansion as demand for advanced tools in drug discovery, toxicology testing, and biomedical research continues to rise. Valued at US$ 20.2 Bn in 2023, the global market is projected to grow at a steady CAGR of 6.4% from 2024 to 2034, ultimately reaching US$ 40.4 Bn by 2034. The market’s momentum is supported by rapid advancements in...